Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial (vol 21, pg 1099, 2022)

被引：0
|
作者：
Soileau, M. J.
Aldread, J.
Budur, K.
机构：
来源：
LANCET NEUROLOGY | 2023年 / 22卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E5 / E5
页数：1
相关论文
共 50 条
  • [21] Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials (vol 21, pg 125, 2022)
    Mignot, E.
    Mayleben, D.
    Fietzeet, I
    LANCET NEUROLOGY, 2022, 21 (03)
  • [22] Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial (vol 43, pg 465, 2024)
    Espay, A. J.
    Stocchi, F.
    Pahwa, R.
    LANCET NEUROLOGY, 2024, 23 (06) : E10 - E10
  • [23] Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study
    Jason Aldred
    Eric Freire-Alvarez
    Alexander V. Amelin
    Angelo Antonini
    Bruno Bergmans
    Filip Bergquist
    Manon Bouchard
    Kumar Budur
    Camille Carroll
    K. Ray Chaudhuri
    Susan R. Criswell
    Erik H. Danielsen
    Florin Gandor
    Jia Jia
    Thomas E. Kimber
    Hideki Mochizuki
    Weining Z. Robieson
    Amy M. Spiegel
    David G. Standaert
    Saritha Talapala
    Maurizio F. Facheris
    Victor S. C. Fung
    Neurology and Therapy, 2023, 12 (6) : 1937 - 1958
  • [24] Efficacy and Safety of Mildronate for Acute Ischemic Stroke: A Randomized, Double-Blind, Active-Controlled Phase II Multicenter Trial
    Zhu, Yi
    Zhang, Guangyun
    Zhao, Jun
    Li, Deshuai
    Yan, Xiaodong
    Liu, Juanfang
    Liu, Xuedong
    Zhao, Haibo
    Xia, Jielai
    Zhang, Xiao
    Li, Zhengyi
    Zhang, Baorong
    Guo, Zongcheng
    Feng, Lianyuan
    Zhang, Zhaodong
    Qu, Fang
    Zhao, Gang
    CLINICAL DRUG INVESTIGATION, 2013, 33 (10) : 755 - 760
  • [25] Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial (vol 21, pg 923, 2020)
    Blay, J-Y
    Serrano, C.
    Heinrich, M. C.
    LANCET ONCOLOGY, 2020, 21 (07) : E341 - E341
  • [26] Efficacy of opicapone in Parkinson's disease patients with motor fluctuations: A phase III, randomized, double-blind, placebo and active-controlled study - BIPARK I
    Ferreira, J.
    Lees, A.
    Santos, A.
    Pinto, R.
    Lopes, N.
    Nunes, T.
    Rocha, J. F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2015, 30 : S85 - S86
  • [27] Efficacy and Safety of Mildronate for Acute Ischemic Stroke: A Randomized, Double-Blind, Active-Controlled Phase II Multicenter Trial
    Yi Zhu
    Guangyun Zhang
    Jun Zhao
    Deshuai Li
    Xiaodong Yan
    Juanfang Liu
    Xuedong Liu
    Haibo Zhao
    Jielai Xia
    Xiao Zhang
    Zhengyi Li
    Baorong Zhang
    Zongcheng Guo
    Lianyuan Feng
    Zhaodong Zhang
    Fang Qu
    Gang Zhao
    Clinical Drug Investigation, 2013, 33 : 755 - 760
  • [28] Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial
    Espay, Alberto J.
    Stocchi, Fabrizio
    Pahwa, Rajesh
    Albanese, Alberto
    Ellenbogen, Aaron
    Ferreira, Joaquim J.
    Giladi, Nir
    Gurevich, Tanya
    Hassin-Baer, Sharon
    Hernandez-Vara, Jorge
    Isaacson, Stuart H.
    Kieburtz, Karl
    Lewitt, Peter A.
    Lopez-Manzanares, Lydia
    Olanow, C. Warren
    Poewe, Werner
    Sarva, Harini
    Yardeni, Tami
    Adar, Liat
    Salin, Laurence
    Lopes, Nelson
    Sasson, Nissim
    Case, Ryan
    Rascol, Olivier
    LANCET NEUROLOGY, 2024, 23 (05) : 465 - 476
  • [29] Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trial
    Feigl, Beatrix
    Lewis, Simon J. G.
    Burr, Lucy D.
    Schweitzer, Daniel
    Gnyawali, Subodh
    Vagenas, Dimitrios
    Carter, Drew D.
    Zele, Andrew J.
    ECLINICALMEDICINE, 2024, 69
  • [30] A Randomized, Double-blind, Active-controlled Exploratory Clinical Trial for the Evaluation of the Efficacy and Safety of Goodmorning S Granule® on Constipation
    Ju, Munjin
    Kim, Nayoung
    Shin, Cheol Min
    Park, Young Soo
    Yoon, Hyuk
    Choi, Yonghun
    Lee, Dong Ho
    KOREAN JOURNAL OF GASTROENTEROLOGY, 2022, 80 (01) : 17 - 27
12345